Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants

Clinical trial NCT00937521 · COMPLETED

Trial details

NCT number: NCT00937521
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Meningitis Meningococcal Infections

Start date: 2009-07-01
Primary completion: 2010-11-01
Enrollment: 1507

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.